e-learning
resources
Virtual 2021
06.09.2021
Comorbidities in airway obstructive diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical COPD Questionnaire results depending on the degree of the inflammatory response in patients with COPD combined with hypertension
A. Melenevych (Kharkiv, Ukraine)
Source:
Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Session:
Comorbidities in airway obstructive diseases
Session type:
E-poster
Number:
2230
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Melenevych (Kharkiv, Ukraine). Clinical COPD Questionnaire results depending on the degree of the inflammatory response in patients with COPD combined with hypertension. 2230
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Nasal high-Flow (NHF) improves ventilation in patients with interstitial lung disease (ILD)
Noninvasive negative pressure ventilation improves survival of COPD patients with exercise desaturation
Cerebral oxygenation in lowlanders with COPD spending a night at 2590m
Related content which might interest you:
Association of inflammatory biomarkers with comorbidity in chronic obstructive pulmonary disease – results from the COSYCONET cohort
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017
Associations between comorbid load and baseline characteristics in COPD patients with comorbidities: Preliminary results
Source: International Congress 2014 – Latest insights in chronic care
Year: 2014
Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations.
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018
Regional differences in the treatment of patients with moderate COPD enrolled in a global clinical trial
Source: Annual Congress 2006 - Recent advances in the treatment of COPD
Year: 2006
Evaluation of the individual bronchodilator response in patients with severe COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 246s
Year: 2002
Features of systemic inflammation in patients with stable COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases
Source: International Congress 2014 – Markers
Year: 2014
The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014
Validation of two physical activity questionnaires in a population of patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 632s
Year: 2004
Baseline data and responses to oral steroid intervention in asthma and COPD: interim report from the BIOAIR EU study
Source: Annual Congress 2007 - Asthma subphenotypes
Year: 2007
Correlation between red cell distribution width and disease severity and mortality in COPD patients
Source: International Congress 2014 – COPD exacerbations
Year: 2014
The relationship between persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort
Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation
Year: 2013
Clinical Impact of Gensini score in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Assessment of treatment efficiency in patients with chronic obstructive pulmonary disease combined with gastroesophageal reflux disease during treatment with melatonin
Source: International Congress 2014 – Clinical presentations
Year: 2014
Prevalence of extra-pulmonary comorbidities in COPD patients and its correlation with severity of disease
Source: International Congress 2014 – Latest insights in chronic care
Year: 2014
Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT
Source: International Congress 2014 – Markers
Year: 2014
Differences in systemic immune function contribute to exacerbation susceptibility in COPD patients
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
COPD and clinical phenotypes: Patients with concomitant pulmonary hypertension may be less likely to be frequent exacerbators
Source: International Congress 2014 – Clinical presentations
Year: 2014
Physical status and dependence levels in patients with COPD exacerbation
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014
Measurement properties of exacerbations of chronic pulmonary disease tool (EXACT) in a clinical trial of patients with moderate to severe COPD
Source: Annual Congress 2013 –Monitoring symptoms and quality of life
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept